| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | UBA5 KIF6 MYH10 ABCA3 ABCB7 ATRX TCP1 ANXA1 MCM2 DNAH7 UBA1 ABCB10 ABCA6 ABCA5 MOV10L1 HELZ2 ATP11A ATP2A2 KIF17 | 1.06e-07 | 614 | 145 | 19 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KIF6 ABCA3 ABCB7 ATRX TCP1 MCM2 DNAH7 ABCB10 ABCA6 ABCA5 MOV10L1 HELZ2 ATP11A ATP2A2 KIF17 | 7.93e-07 | 441 | 145 | 15 | GO:0016887 |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 2.78e-05 | 49 | 145 | 5 | GO:0140359 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | KIF6 ABCA3 ABCB7 ATRX SEPTIN4 TCP1 DCP2 MCM2 DNAH7 ABCB10 ABCA6 ABCA5 MOV10L1 HELZ2 RASEF ATP11A ATP2A2 KIF17 | 3.84e-05 | 839 | 145 | 18 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | KIF6 ABCA3 ABCB7 ATRX SEPTIN4 TCP1 DCP2 MCM2 DNAH7 ABCB10 ABCA6 ABCA5 MOV10L1 HELZ2 RASEF ATP11A ATP2A2 KIF17 | 3.90e-05 | 840 | 145 | 18 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | KIF6 ABCA3 ABCB7 ATRX SEPTIN4 TCP1 DCP2 MCM2 DNAH7 ABCB10 ABCA6 ABCA5 MOV10L1 HELZ2 RASEF ATP11A ATP2A2 KIF17 | 3.90e-05 | 840 | 145 | 18 | GO:0016818 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | KIF6 ABCA3 ABCB7 ATRX SEPTIN4 TCP1 MCM2 DNAH7 ABCB10 ABCA6 ABCA5 MOV10L1 HELZ2 RASEF ATP11A ATP2A2 KIF17 | 4.87e-05 | 775 | 145 | 17 | GO:0017111 |
| GeneOntologyMolecularFunction | RNA nuclease activity | 6.16e-05 | 136 | 145 | 7 | GO:0004540 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 1.45e-04 | 109 | 145 | 6 | GO:0042626 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | EXOSC9 CMTR1 ATRX ANXA1 POLH KHNYN DCP2 MCM2 ALKBH8 AGO1 SND1 NYNRIN MOV10L1 HELZ2 | 2.60e-04 | 645 | 145 | 14 | GO:0140640 |
| GeneOntologyMolecularFunction | ribose phosphate diphosphokinase activity | 5.16e-04 | 5 | 145 | 2 | GO:0004749 | |
| GeneOntologyMolecularFunction | phospholipid binding | ZFYVE16 ANXA1 PCLO RNF34 SCARB2 SVIL OSBPL10 PLD1 NCF1C NCF1B ARAP1 CPNE7 | 6.69e-04 | 548 | 145 | 12 | GO:0005543 |
| GeneOntologyMolecularFunction | syntaxin-1 binding | 6.79e-04 | 24 | 145 | 3 | GO:0017075 | |
| GeneOntologyMolecularFunction | diphosphotransferase activity | 7.71e-04 | 6 | 145 | 2 | GO:0016778 | |
| GeneOntologyMolecularFunction | lipid binding | ZFYVE16 ANXA1 PCLO SH3GL2 SHBG ACOT7 RNF34 INPP4B SCARB2 SVIL OSBPL10 SNAP25 PLD1 NCF1C NCF1B ARAP1 CPNE7 | 8.40e-04 | 988 | 145 | 17 | GO:0008289 |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | EXOSC9 CMTR1 KHNYN DCP2 ALKBH8 AGO1 SND1 NYNRIN MOV10L1 HELZ2 | 9.56e-04 | 417 | 145 | 10 | GO:0140098 |
| GeneOntologyMolecularFunction | RNA polymerase binding | 1.28e-03 | 65 | 145 | 4 | GO:0070063 | |
| GeneOntologyMolecularFunction | nuclease activity | 1.52e-03 | 231 | 145 | 7 | GO:0004518 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.71e-03 | 118 | 145 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 1.93e-03 | 178 | 145 | 6 | GO:0015399 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 2.07e-03 | 74 | 145 | 4 | GO:0005548 | |
| GeneOntologyMolecularFunction | magnesium ion binding | 2.21e-03 | 247 | 145 | 7 | GO:0000287 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | PALD1 EXOSC9 CES5A KHNYN DCP2 ACOT7 H6PD INPP4B AGO1 SND1 NYNRIN PTPRQ HELZ2 PLD1 | 2.26e-03 | 807 | 145 | 14 | GO:0016788 |
| GeneOntologyMolecularFunction | superoxide-generating NADPH oxidase activator activity | 2.27e-03 | 10 | 145 | 2 | GO:0016176 | |
| GeneOntologyMolecularFunction | ubiquitin-like modifier activating enzyme activity | 2.27e-03 | 10 | 145 | 2 | GO:0008641 | |
| GeneOntologyBiologicalProcess | neutrophil-mediated killing of fungus | 1.05e-05 | 7 | 140 | 3 | GO:0070947 | |
| GeneOntologyCellularComponent | ribbon synapse | 6.33e-05 | 32 | 142 | 4 | GO:0097470 | |
| GeneOntologyCellularComponent | cell body | MYH10 SEPTIN4 TCP1 AZIN2 PARK7 PCLO SH3GL2 ACOT7 SRR TTLL7 ARG1 CNNM4 SLC8A3 AKAP9 SNAP25 NCF1C NCF1B | 1.93e-04 | 929 | 142 | 17 | GO:0044297 |
| GeneOntologyCellularComponent | ribose phosphate diphosphokinase complex | 4.52e-04 | 5 | 142 | 2 | GO:0002189 | |
| GeneOntologyCellularComponent | neuronal cell body | MYH10 SEPTIN4 AZIN2 PCLO SH3GL2 ACOT7 SRR TTLL7 ARG1 CNNM4 SLC8A3 AKAP9 SNAP25 NCF1C NCF1B | 5.68e-04 | 835 | 142 | 15 | GO:0043025 |
| GeneOntologyCellularComponent | somatodendritic compartment | MYH10 SEPTIN4 IFT57 AZIN2 FAT3 PCLO SH3GL2 ANKS1B ACOT7 SRR TTLL7 ARG1 CNNM4 SLC8A3 AKAP9 SNAP25 NCF1C KIF17 NCF1B | 6.59e-04 | 1228 | 142 | 19 | GO:0036477 |
| GeneOntologyCellularComponent | dendrite | MYH10 SEPTIN4 IFT57 AZIN2 FAT3 PCLO SH3GL2 ANKS1B TTLL7 CNNM4 SLC8A3 AKAP9 NCF1C KIF17 NCF1B | 7.50e-04 | 858 | 142 | 15 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | MYH10 SEPTIN4 IFT57 AZIN2 FAT3 PCLO SH3GL2 ANKS1B TTLL7 CNNM4 SLC8A3 AKAP9 NCF1C KIF17 NCF1B | 7.68e-04 | 860 | 142 | 15 | GO:0097447 |
| GeneOntologyCellularComponent | specific granule | 7.95e-04 | 160 | 142 | 6 | GO:0042581 | |
| GeneOntologyCellularComponent | pericentriolar material | 8.88e-04 | 28 | 142 | 3 | GO:0000242 | |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | 9.12e-04 | 443 | 142 | 10 | GO:0098791 | |
| GeneOntologyCellularComponent | anchoring junction | ANXA1 PARK7 TRPC4 ITGA2 PPIB DES SLC8A3 UBA1 XIRP2 SCARB2 SVIL PRKAR2A TLN2 PRKD1 ATP2A2 EPB41L2 | 9.87e-04 | 976 | 142 | 16 | GO:0070161 |
| GeneOntologyCellularComponent | cell cortex | 9.99e-04 | 371 | 142 | 9 | GO:0005938 | |
| GeneOntologyCellularComponent | neuromuscular junction | 1.01e-03 | 112 | 142 | 5 | GO:0031594 | |
| GeneOntologyCellularComponent | trans-Golgi network | 1.19e-03 | 306 | 142 | 8 | GO:0005802 | |
| Domain | ABC_tran | 3.01e-05 | 48 | 141 | 5 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 3.01e-05 | 48 | 141 | 5 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 3.33e-05 | 49 | 141 | 5 | PS00211 | |
| Domain | ABC_transporter-like | 3.68e-05 | 50 | 141 | 5 | IPR003439 | |
| Domain | ABC_A | 8.82e-05 | 12 | 141 | 3 | IPR026082 | |
| Domain | AAA | 1.12e-04 | 144 | 141 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 1.12e-04 | 144 | 141 | 7 | IPR003593 | |
| Domain | PRPP_SYNTHASE | 1.69e-04 | 3 | 141 | 2 | PS00114 | |
| Domain | PRib_PP_synth_CS | 1.69e-04 | 3 | 141 | 2 | IPR000842 | |
| Domain | ABC_transporter_CS | 2.79e-04 | 42 | 141 | 4 | IPR017871 | |
| Domain | DUF21 | 3.36e-04 | 4 | 141 | 2 | IPR002550 | |
| Domain | DUF21 | 3.36e-04 | 4 | 141 | 2 | PF01595 | |
| Domain | Pribosyltran_N | 5.58e-04 | 5 | 141 | 2 | PF13793 | |
| Domain | Pribosyl_synth | 5.58e-04 | 5 | 141 | 2 | PF14572 | |
| Domain | Rib-P_diPkinase | 5.58e-04 | 5 | 141 | 2 | IPR005946 | |
| Domain | Pribosyltran_N | 5.58e-04 | 5 | 141 | 2 | IPR029099 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 2.79e-05 | 44 | 115 | 5 | M11911 | |
| Pubmed | MYH10 ILF3 SEPTIN4 TCP1 ANXA1 PARK7 PCLO HNRNPM ANKS1B ACOT7 ITGA2 PPIB JMY UBA1 FBXL16 AGO1 SND1 SVIL PDE4DIP OSBPL10 PRKAR2A TLN2 VPS51 ATP2A2 EPB41L2 PRPS1 | 3.85e-10 | 1431 | 148 | 26 | 37142655 | |
| Pubmed | CCDC22 ILF3 CASP14 CMTR1 ZFYVE16 PARK7 POLH NACA PPIB RIF1 BAZ1A PRKAR2A TLN2 RPRD2 CPSF2 | 1.98e-09 | 472 | 148 | 15 | 38943005 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EXOSC9 ILF3 CASP14 TCP1 ANXA1 NACA MCM2 PPIB ARG1 RIF1 URB1 UBA1 STXBP2 SND1 BAZ1A VANGL1 MYL6B SVIL CPSF2 ATP2A2 EPB41L2 | 2.79e-09 | 1024 | 148 | 21 | 24711643 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | PRPS2 EXOSC9 MYH10 ILF3 TCP1 ANXA1 PARK7 KHNYN NACA HNRNPM ACOT7 MCM2 PPIB UBA1 STXBP2 SND1 SVIL PRKAR2A ATP2A2 EPB41L2 PRPS1 | 2.05e-08 | 1149 | 148 | 21 | 35446349 |
| Pubmed | MYH10 ILF3 PARK7 TRPC4 SH3GL2 HNRNPM ANKS1B PPIB UBA1 AGO1 AKAP9 SVIL PDE4DIP PRKAR2A TLN2 PRKD1 CPSF2 ARHGEF26 EPB41L2 | 3.12e-08 | 963 | 148 | 19 | 28671696 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | EXOSC9 MYH10 ILF3 ATRX TCP1 PARK7 PCLO NACA HNRNPM MCM2 PPIB RIF1 URB1 UBA1 STXBP3 SND1 BAZ1A PRKAR2A TLN2 BOD1L1 ATP2A2 EPB41L2 PRPS1 | 3.98e-08 | 1425 | 148 | 23 | 30948266 |
| Pubmed | BDP1 KIF6 ILF3 FAM185A TRPC4 SH3GL2 PYROXD2 ANKS1B CUL9 TTLL7 TMEM132D RIN2 MOV10L1 RASEF PRKD1 CPSF2 CLEC16A | 7.83e-08 | 814 | 148 | 17 | 23251661 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | PALD1 MYH10 ILF3 ATRX ZFYVE16 TCP1 PARK7 NACA HNRNPM KDM3B ACOT7 RIF1 UBA1 SND1 BAZ1A RPRD2 BOD1L1 EPB41L2 | 1.05e-07 | 934 | 148 | 18 | 33916271 |
| Pubmed | PALD1 MYH10 ZFYVE16 KHNYN CUL9 ADCY6 AKAP9 PDE4DIP BOD1L1 KIF17 CLEC16A SENP7 | 1.96e-07 | 407 | 148 | 12 | 12693553 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | UBA5 RNF130 ILF3 ATRX TCP1 HNRNPM RNF17 RIF1 SND1 BRD4 TLN2 CPSF2 VPS51 ARAP1 | 2.19e-07 | 582 | 148 | 14 | 20467437 |
| Pubmed | 3.01e-07 | 4 | 148 | 3 | 26021615 | ||
| Pubmed | MYH10 ILF3 CASP14 TCP1 ANXA1 PARK7 NACA HNRNPM ACOT7 MCM2 PPIB ARG1 UBA1 SND1 HELZ2 ATP2A2 | 3.62e-07 | 803 | 148 | 16 | 36517590 | |
| Pubmed | MYH10 CCDC22 ZFYVE16 TCP1 IFT57 PPIB POSTN CNNM4 RIF1 UBA1 FBXL16 AKAP9 STXBP3 VANGL1 SVIL TMF1 CPSF2 ATP2A2 | 5.71e-07 | 1049 | 148 | 18 | 27880917 | |
| Pubmed | PRPS2 MYH10 ILF3 ATRX MTRES1 PCLO HNRNPM ANKS1B RNF17 PPIB ADCY6 SCML4 DES STXBP2 KIAA0825 SND1 BAZ1A BOD1L1 ATP11A ATP2A2 PRPS1 | 8.80e-07 | 1442 | 148 | 21 | 35575683 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | MYH10 ILF3 CASP14 TCP1 TRPC4 NACA HNRNPM MCM2 PPIB UBA1 SND1 ATP2A2 | 1.05e-06 | 477 | 148 | 12 | 31300519 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYH10 CCDC22 ILF3 CASP14 TCP1 ANXA1 PARK7 NACA HNRNPM ACOT7 MCM2 PPIB ARG1 RIF1 URB1 UBA1 SND1 BAZ1A ATP2A2 EPB41L2 | 1.31e-06 | 1353 | 148 | 20 | 29467282 |
| Pubmed | EXOSC9 MYH10 ILF3 TCP1 ANXA1 DCP2 NACA KBTBD8 PPIB RIF1 AKAP9 BAZ1A MYL6B PCSK6 SVIL HELZ2 PLD1 CPSF2 EPB41L2 CPNE7 | 1.60e-06 | 1371 | 148 | 20 | 36244648 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.75e-06 | 332 | 148 | 10 | 32786267 | |
| Pubmed | MYH10 ANXA1 PARK7 PCLO SH3GL2 NACA HNRNPM ANKS1B UBA1 KCNQ5 PDE4DIP PRKAR2A TLN2 SNAP25 VPS51 ATP2A2 CLEC16A EPB41L2 | 1.84e-06 | 1139 | 148 | 18 | 36417873 | |
| Pubmed | 1.92e-06 | 135 | 148 | 7 | 31405213 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | MYH10 ILF3 TCP1 ANXA1 PARK7 PCLO HNRNPM ACOT7 PPIB AKAP9 STXBP3 SND1 MOV10L1 ATP2A2 PRPS1 | 2.02e-06 | 807 | 148 | 15 | 30575818 |
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | PRPS2 TCP1 ANXA1 PPIB UBA1 STXBP3 SND1 MYL6B SCARB2 ATP2A2 PRPS1 | 2.13e-06 | 422 | 148 | 11 | 27342126 |
| Pubmed | 2.61e-06 | 7 | 148 | 3 | 11544318 | ||
| Pubmed | 2.61e-06 | 7 | 148 | 3 | 9494100 | ||
| Pubmed | Cloning and functional expression of the mouse homologue of p47phox. | 2.61e-06 | 7 | 148 | 3 | 8119734 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 3.33e-06 | 357 | 148 | 10 | 37059091 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 3.76e-06 | 283 | 148 | 9 | 30585729 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | CNNM2 ABCB7 CCDC22 CMTR1 LSM3 URB1 AKAP9 STXBP3 SND1 MYL6B BRD4 PCSK6 PDE4DIP PRKAR2A | 4.56e-06 | 754 | 148 | 14 | 33060197 |
| Pubmed | 4.82e-06 | 155 | 148 | 7 | 33838681 | ||
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | 5.14e-06 | 221 | 148 | 8 | 29991511 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | BDP1 RNF130 MYH10 SGSM1 ATRX H6PD ZP3 CNNM4 KCNQ5 RIN2 RASEF RPRD2 BOD1L1 ATP11A PRKD1 ARHGEF26 CLEC16A ARAP1 EVI5L CPNE7 | 5.53e-06 | 1489 | 148 | 20 | 28611215 |
| Pubmed | UBA5 ABCB7 ZFYVE16 TCP1 PARK7 NACA HNRNPM ACOT7 SRR UBA1 ABCB10 ATP2A2 EPB41L2 TANGO6 PRPS1 | 5.59e-06 | 878 | 148 | 15 | 37223481 | |
| Pubmed | 5.87e-06 | 225 | 148 | 8 | 12168954 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ILF3 ATRX KDM3B MCM2 ADCY6 RIF1 UBA1 BRD4 SVIL HELZ2 TLN2 CPSF2 ATP2A2 EPB41L2 | 6.14e-06 | 774 | 148 | 14 | 15302935 |
| Pubmed | 6.23e-06 | 9 | 148 | 3 | 10433265 | ||
| Pubmed | 6.89e-06 | 305 | 148 | 9 | 33194618 | ||
| Pubmed | 7.55e-06 | 166 | 148 | 7 | 34687317 | ||
| Pubmed | 7.57e-06 | 233 | 148 | 8 | 37704626 | ||
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | PRPS2 MYH10 TCP1 ANXA1 NACA HNRNPM PPIB DES UBA1 MYL6B SVIL EPB41L2 | 7.71e-06 | 580 | 148 | 12 | 35676659 |
| Pubmed | MYH10 ABCB7 ILF3 HNRNPM CNNM4 URB1 UBA1 STXBP3 SND1 SCARB2 EPB41L2 | 7.82e-06 | 484 | 148 | 11 | 31995728 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 7.91e-06 | 394 | 148 | 10 | 27248496 | |
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 8.17e-06 | 168 | 148 | 7 | 30631154 | |
| Pubmed | 8.45e-06 | 397 | 148 | 10 | 21319273 | ||
| Pubmed | CASP14 ANXA1 SH3GL2 NACA MCM2 PPIB RIF1 UBA1 MYL6B PRKAR2A CPSF2 ARHGEF26 EPB41L2 ARAP1 EVI5L | 9.24e-06 | 916 | 148 | 15 | 32203420 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | MYH10 ANXA1 PARK7 PCLO MCM2 STXBP3 SVIL PRKAR2A TLN2 BOD1L1 PRPS1 | 1.02e-05 | 498 | 148 | 11 | 36634849 |
| Pubmed | PALD1 ILF3 ZFYVE16 TCP1 HNRNPM PPIB UBA1 SND1 VANGL1 BOD1L1 ARHGEF26 ATP2A2 EPB41L2 | 1.14e-05 | 708 | 148 | 13 | 39231216 | |
| Pubmed | 1.20e-05 | 327 | 148 | 9 | 31409639 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | PRPS2 PALD1 EXOSC9 ATRX IFT57 MCM2 DPP8 ADCY6 POSTN CNNM4 RIF1 UBA1 SND1 MYL6B PTPRQ PRKD1 VPS51 CCDC144A | 1.40e-05 | 1321 | 148 | 18 | 27173435 |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 31383768 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 26086043 | ||
| Pubmed | EB1 recognizes the nucleotide state of tubulin in the microtubule lattice. | 1.80e-05 | 2 | 148 | 2 | 19851462 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 19561090 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 34289528 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 18409517 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 33675805 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 23178798 | ||
| Pubmed | PRPS1-mediated purine biosynthesis is critical for pluripotent stem cell survival and stemness. | 1.80e-05 | 2 | 148 | 2 | 33493137 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 38149326 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 24706765 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 2537655 | ||
| Pubmed | Munc18-syntaxin complexes and exocytosis in human platelets. | 1.80e-05 | 2 | 148 | 2 | 12649283 | |
| Pubmed | MYH10 ILF3 CASP14 ANXA1 PARK7 HNRNPM ACOT7 CUL9 UBA1 SND1 RIN2 SVIL | 1.86e-05 | 634 | 148 | 12 | 34591612 | |
| Pubmed | UBA5 MYH10 ILF3 TCP1 HNRNPM MCM2 RIF1 UBA1 SND1 PRKAR2A ATP2A2 EPB41L2 | 1.98e-05 | 638 | 148 | 12 | 33239621 | |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 2.08e-05 | 268 | 148 | 8 | 33024031 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYH10 ABCB7 ANXA1 PARK7 HNRNPM MCM2 ITGA2 DES UBA1 ABCB10 RASEF ATP2A2 | 2.27e-05 | 647 | 148 | 12 | 26618866 |
| Pubmed | ILF3 CASP14 ATRX ANXA1 NACA HNRNPM MCM2 PPIB ARG1 RIF1 SVIL ATP2A2 | 2.45e-05 | 652 | 148 | 12 | 31180492 | |
| Pubmed | MYH10 ILF3 TCP1 ANXA1 PARK7 SH3GL2 HNRNPM ACOT7 UBA1 SNAP25 EPB41L2 | 2.63e-05 | 552 | 148 | 11 | 36293380 | |
| Pubmed | Fyn Regulates Binding Partners of Cyclic-AMP Dependent Protein Kinase A. | 2.73e-05 | 82 | 148 | 5 | 30274258 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 2.78e-05 | 203 | 148 | 7 | 22083510 | |
| Pubmed | TCP1 HNRNPM KDM3B DNAH7 RIF1 VANGL1 PKLR OSBPL10 TMF1 PLD1 CLEC16A EPB41L2 PRPS1 | 3.01e-05 | 777 | 148 | 13 | 35844135 | |
| Pubmed | RNA binding proteins co-localize with small tau inclusions in tauopathy. | 3.07e-05 | 283 | 148 | 8 | 30068389 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 3.09e-05 | 462 | 148 | 10 | 31138677 | |
| Pubmed | 3.22e-05 | 285 | 148 | 8 | 21423176 | ||
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 3.24e-05 | 208 | 148 | 7 | 33230847 | |
| Pubmed | CASP14 ANXA1 PARK7 NACA ACOT7 MCM2 DES UBA1 SND1 TMF1 PRKAR2A ATP2A2 PRPS1 | 3.38e-05 | 786 | 148 | 13 | 29128334 | |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | CNNM2 ILF3 TCP1 PARK7 PPIB CNNM4 RIF1 UBA1 AGO1 VANGL1 ATP2A2 | 3.69e-05 | 573 | 148 | 11 | 28330616 |
| Pubmed | MYH10 ABCB7 ZFYVE16 TCP1 PARK7 KDM3B MCM2 UBA1 SND1 BAZ1A VANGL1 SCARB2 PRKAR2A BOD1L1 ATP11A ATP2A2 EPB41L2 | 4.00e-05 | 1297 | 148 | 17 | 33545068 | |
| Pubmed | 4.06e-05 | 382 | 148 | 9 | 37249651 | ||
| Pubmed | PALD1 EXOSC9 MYH10 ABCB7 CCDC22 TCP1 NACA MCM2 JMY CNNM4 URB1 SND1 MYL6B SCARB2 SNAP25 ATP2A2 EVI5L PRPS1 | 4.33e-05 | 1440 | 148 | 18 | 30833792 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | PRPS2 MYH10 ILF3 TCP1 NACA HNRNPM KDM3B ACOT7 MCM2 PPIB STXBP2 ABCB10 SND1 PKLR CPSF2 ATP2A2 PRPS1 | 4.88e-05 | 1318 | 148 | 17 | 30463901 |
| Pubmed | Evidence of Xist RNA-independent initiation of mouse imprinted X-chromosome inactivation. | 4.91e-05 | 17 | 148 | 3 | 19571810 | |
| Pubmed | Colitis susceptibility in p47(phox-/-) mice is mediated by the microbiome. | 5.38e-05 | 3 | 148 | 2 | 27044504 | |
| Pubmed | NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury. | 5.38e-05 | 3 | 148 | 2 | 18787174 | |
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 24873968 | ||
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 22184329 | ||
| Pubmed | Natural Loss-of-Function Mutations in Qa2 and NCF1 Cause the Spread of Mannan-Induced Psoriasis. | 5.38e-05 | 3 | 148 | 2 | 33545139 | |
| Pubmed | Small-molecule screen identifies reactive oxygen species as key regulators of neutrophil chemotaxis. | 5.38e-05 | 3 | 148 | 2 | 20142487 | |
| Pubmed | p47(phox) contributes to albuminuria and kidney fibrosis in mice. | 5.38e-05 | 3 | 148 | 2 | 25565313 | |
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 39357591 | ||
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 11435342 | ||
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 31118934 | ||
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 16041040 | ||
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 1314091 | ||
| Pubmed | Intermittent hypoxia has organ-specific effects on oxidative stress. | 5.38e-05 | 3 | 148 | 2 | 18703411 | |
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 17307863 | ||
| Pubmed | Ncf1 affects osteoclast formation but is not critical for postmenopausal bone loss. | 5.38e-05 | 3 | 148 | 2 | 27829407 | |
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 22376231 | ||
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 23918780 | ||
| Pubmed | NADPH oxidase NOX2 mediates TLR2/6-dependent release of GM-CSF from endothelial cells. | 5.38e-05 | 3 | 148 | 2 | 28274989 | |
| Pubmed | Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. | 5.38e-05 | 3 | 148 | 2 | 12364355 | |
| Interaction | PPIA interactions | RNF130 CCDC22 ILF3 CASP14 CMTR1 ZFYVE16 TCP1 ANXA1 PARK7 POLH NACA HNRNPM ACOT7 MCM2 PPIB RIF1 BAZ1A PRKAR2A TLN2 RPRD2 CPSF2 SENP7 | 3.47e-07 | 888 | 144 | 22 | int:PPIA |
| Interaction | SUMO2 interactions | EXOSC9 ATRX TCP1 ANXA1 PARK7 NACA HNRNPM PPIB RIF1 UBA1 SND1 BAZ1A BRD4 BOD1L1 ZCCHC7 CPSF2 SENP7 | 1.15e-06 | 591 | 144 | 17 | int:SUMO2 |
| Interaction | CCDC8 interactions | ILF3 CASP14 TCP1 NACA CUL9 MCM2 ARG1 UBA1 AGO1 STXBP2 SND1 BAZ1A VANGL1 MYL6B SVIL ATP2A2 EPB41L2 | 4.66e-06 | 656 | 144 | 17 | int:CCDC8 |
| Interaction | KCTD13 interactions | MYH10 ILF3 SEPTIN4 TCP1 ANXA1 PARK7 PCLO HNRNPM ANKS1B ACOT7 ITGA2 PPIB JMY LSM3 UBA1 FBXL16 AGO1 SND1 SVIL OSBPL10 PRKAR2A TLN2 VPS51 ATP2A2 EPB41L2 | 1.74e-05 | 1394 | 144 | 25 | int:KCTD13 |
| GeneFamily | ATP binding cassette subfamily A | 5.72e-05 | 14 | 100 | 3 | 805 | |
| GeneFamily | Ubiquitin like modifier activating enzymes | 1.32e-03 | 10 | 100 | 2 | 100 | |
| GeneFamily | ATP binding cassette subfamily B | 1.61e-03 | 11 | 100 | 2 | 806 | |
| GeneFamily | UPF1 like RNA helicases | 1.61e-03 | 11 | 100 | 2 | 1169 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 7.89e-10 | 188 | 148 | 10 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | MYH10 CNNM2 FAT3 TRPC4 ANKS1B INPP4B TTLL7 KCNQ5 PRKD1 ARHGEF26 | 8.31e-10 | 189 | 148 | 10 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c |
| ToppCell | droplet-Liver-Npc-21m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.95e-09 | 75 | 148 | 7 | 7f3be37cc378ee115fcb4b0eb9653fc77447aa0a | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-08 | 195 | 148 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.21e-07 | 173 | 148 | 8 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.80e-07 | 193 | 148 | 8 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 3.02e-07 | 195 | 148 | 8 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-07 | 195 | 148 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 3.27e-07 | 197 | 148 | 8 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 3.40e-07 | 198 | 148 | 8 | e0e47cf65774191981840b22905b2094b95abe0f | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 3.67e-07 | 200 | 148 | 8 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 2.43e-06 | 180 | 148 | 7 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l14|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.52e-06 | 116 | 148 | 6 | f2bf9599040f43b5ea8724841d7b71c0a859c016 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 2.71e-06 | 183 | 148 | 7 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.71e-06 | 183 | 148 | 7 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.23e-06 | 188 | 148 | 7 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.47e-06 | 190 | 148 | 7 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.47e-06 | 190 | 148 | 7 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.71e-06 | 124 | 148 | 6 | 80526f503e1477b9455d10f27f7e6b56caea3a66 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.72e-06 | 192 | 148 | 7 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.85e-06 | 193 | 148 | 7 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.85e-06 | 193 | 148 | 7 | bdb7401dd9059032f930f2b575f2ef8e504b6594 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.98e-06 | 194 | 148 | 7 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.98e-06 | 194 | 148 | 7 | cf0244a29934e515446ac917d3c30672b460fb04 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.98e-06 | 194 | 148 | 7 | ba7f971fb9a19423602da60770f23d9fead4a451 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 4.12e-06 | 195 | 148 | 7 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.26e-06 | 196 | 148 | 7 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.26e-06 | 196 | 148 | 7 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.26e-06 | 196 | 148 | 7 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.40e-06 | 197 | 148 | 7 | 156155c2f0c1a2461e45803da578af18ee221660 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.40e-06 | 197 | 148 | 7 | d5d9263451f6c10cb3b9c17740183ca334e24851 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 4.70e-06 | 199 | 148 | 7 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 4.70e-06 | 199 | 148 | 7 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.86e-06 | 200 | 148 | 7 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 4.86e-06 | 200 | 148 | 7 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.86e-06 | 200 | 148 | 7 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.86e-06 | 200 | 148 | 7 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital|World / Primary Cells by Cluster | 4.86e-06 | 200 | 148 | 7 | 6bbe8e1f3e91678f1bfb14945365c1578a59a604 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital-19|World / Primary Cells by Cluster | 4.86e-06 | 200 | 148 | 7 | c831d9e0a7178e3634da45548f91fa9e8dc6557c | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.86e-06 | 200 | 148 | 7 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_granulocytic-mast_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.54e-05 | 159 | 148 | 6 | ecd1daa33549541aee3bf4e139ab6732efc8e74c | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_granulocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.54e-05 | 159 | 148 | 6 | 7b6370c9567da7d40541c6e243efa704ed7e90ae | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.72e-05 | 162 | 148 | 6 | 502ed67f6a572f10ac6e22948a1747d8214eb974 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.72e-05 | 162 | 148 | 6 | 82e782096f89cd03d1fdf599ba727d6f23e35e2d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.72e-05 | 162 | 148 | 6 | 6bed33b17b59812646dc6a29c1d87413bad86c11 | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.90e-05 | 165 | 148 | 6 | 3d2acdae0dd2b79a15f74158e8e566ce22b4218e | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_DC-DC-pDC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.97e-05 | 166 | 148 | 6 | 9fa90d9d484563d44738bb2c6eb0775dffc4d549 | |
| ToppCell | Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.01e-05 | 99 | 148 | 5 | 98c40a27432929434879c9e7283a14102f405f39 | |
| ToppCell | Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.01e-05 | 99 | 148 | 5 | d6bd8075dc7aba2034ea78b1389868282bc80a2d | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Progenitor|lymph-node_spleen / Manually curated celltypes from each tissue | 2.04e-05 | 167 | 148 | 6 | cb396f3edb9e8fdc316091e8e193dbba50e0be0c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.41e-05 | 172 | 148 | 6 | 08a3fe536b1b064c5ee7779bc2b1115a5963a26b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.41e-05 | 172 | 148 | 6 | 553701349444eb366df3c11f54bb093434f153c6 | |
| ToppCell | Endothelial-Endothelial-G|Endothelial / shred on cell class and cell subclass (v4) | 2.41e-05 | 172 | 148 | 6 | 644f8e42ee8d8996f6ae50cdf874559be55509fc | |
| ToppCell | AT1-AT2_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 2.65e-05 | 175 | 148 | 6 | 9a95ab5c361ebaa8747983c5a0d69025682a19ad | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.74e-05 | 176 | 148 | 6 | bd5c85b3a4fb88ffe156599f6d224aa7664a513a | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.74e-05 | 176 | 148 | 6 | a9e77681bcd36c382d53eb6f771349d55f98d744 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-05 | 179 | 148 | 6 | c7c74e26bbf86c5326ee38bac7de111d5414f46b | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Lymphocytic-T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-05 | 180 | 148 | 6 | 87347af8f28cf7c486c19f3f98c0afb022c323b5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.30e-05 | 182 | 148 | 6 | 14a117c5e50db31ee1b2cf4df4d133451fd6d55f | |
| ToppCell | hematopoetic_progenitors-CD34+_MEP_2|World / Lineage and Cell class | 3.30e-05 | 182 | 148 | 6 | a7e7aa10f14111a6c7ba22e0f1668dcaa124714d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.51e-05 | 184 | 148 | 6 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.62e-05 | 185 | 148 | 6 | b1e84228c95be8ccf7c3c1afb66b71ffb93cf61e | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.73e-05 | 186 | 148 | 6 | db9b67066fc003c7995ec205d15176bf40c97add | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-05 | 187 | 148 | 6 | a12f383b02b07af32cc53a154685df8dba8fbd3f | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-05 | 187 | 148 | 6 | c40c152fa14e6afc9188549534b64ccbaded56b3 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 3.84e-05 | 187 | 148 | 6 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 3.84e-05 | 187 | 148 | 6 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.96e-05 | 188 | 148 | 6 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.96e-05 | 188 | 148 | 6 | a906c29e3fda22eecfec3e5cac706c417bf2b7a4 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.08e-05 | 189 | 148 | 6 | 26cfe5b7e7f477f225f4e9f25f983f432f01e183 | |
| ToppCell | LPS_only-Unknown-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.13e-05 | 115 | 148 | 5 | ad5298c2ad8bf94fa13c2e50b0799e929473ef59 | |
| ToppCell | LPS_only-Unknown|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.13e-05 | 115 | 148 | 5 | 7a733f6987b40ec497a03734b79ed5355ad3a2fc | |
| ToppCell | LPS_only-Unknown-Endothelial-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.13e-05 | 115 | 148 | 5 | c67145d3cd9243994a141749b426ff2a6dcc8d93 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.20e-05 | 190 | 148 | 6 | 2ab604d35456beba71c25511e0f819000e6642d2 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.20e-05 | 190 | 148 | 6 | 7e4d80a3a7f83b6a50f1d0fe82fb6c242c39d5b0 | |
| ToppCell | ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.20e-05 | 190 | 148 | 6 | 9ce301841ce9486701fa28eb2a9929e35d476878 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.20e-05 | 190 | 148 | 6 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.20e-05 | 190 | 148 | 6 | 951e067d14412db67dc3babcdf61e41717d7b429 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.20e-05 | 190 | 148 | 6 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.20e-05 | 190 | 148 | 6 | 979b1476fd2692fde977ce56257315fcfc8a01d5 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.20e-05 | 190 | 148 | 6 | 7fec459cd2ad12c2923a03d098289337c0a4c1d3 | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.20e-05 | 190 | 148 | 6 | 84fbd5664ec886120963d4f50dfa1fd1851d36c1 | |
| ToppCell | LPS-IL1RA-Endothelial-Epi-like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.30e-05 | 116 | 148 | 5 | cf4e3c34570f57502ec524881d351ef8e47976d2 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.32e-05 | 191 | 148 | 6 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-05 | 191 | 148 | 6 | 9c5d88f0d3c834c2419ec3da74652175153ba9df | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.32e-05 | 191 | 148 | 6 | 5a67ff17fb4b9eff641176dff07830c9cd73754e | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 4.32e-05 | 191 | 148 | 6 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.32e-05 | 191 | 148 | 6 | 55ab2854a02cdcfc395e49870ccb7290b5e5471d | |
| ToppCell | P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.32e-05 | 191 | 148 | 6 | 2ad717b59215ad8d933e9637d363b65d7298e5d4 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.32e-05 | 191 | 148 | 6 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-05 | 191 | 148 | 6 | a7494191a92984e5f53610bbbedd6714e9169e1c | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 4.45e-05 | 192 | 148 | 6 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 4.45e-05 | 192 | 148 | 6 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.45e-05 | 192 | 148 | 6 | 063e119c4b58957643908f667e6cfd6f7517fd03 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 4.45e-05 | 192 | 148 | 6 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.58e-05 | 193 | 148 | 6 | 8d05805295c5d3aa93aeb38be5fbefa81e1be1f0 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.58e-05 | 193 | 148 | 6 | 1b2cc627b2aa002b442358bd1188d470e67ce7d9 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 4.58e-05 | 193 | 148 | 6 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | Control-Lymphoid-pDC|Lymphoid / Condition, Lineage and Cell class | 4.72e-05 | 194 | 148 | 6 | 5f95a5a35f73222dbe2ca52cc580f4774f641403 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 4.72e-05 | 194 | 148 | 6 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| Disease | Malignant neoplasm of breast | KIF6 ABCA3 TCP1 POLH TRPC4 KBTBD8 H6PD INPP4B CNNM4 DES RIF1 SLC8A3 ALKBH8 AKAP9 ABCB10 BOD1L1 PRPS1 | 2.24e-05 | 1074 | 145 | 17 | C0006142 |
| Disease | periostin measurement | 1.43e-04 | 4 | 145 | 2 | EFO_0020628 | |
| Disease | chronic granulomatous disease (implicated_via_orthology) | 2.38e-04 | 5 | 145 | 2 | DOID:3265 (implicated_via_orthology) | |
| Disease | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | 4.79e-04 | 200 | 145 | 6 | EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351 | |
| Disease | stromal cell-derived factor 1 measurement | 4.96e-04 | 7 | 145 | 2 | EFO_0020756 | |
| Disease | peripheral neuropathy | 4.96e-04 | 7 | 145 | 2 | EFO_0003100 | |
| Disease | bipolar I disorder | 6.76e-04 | 141 | 145 | 5 | EFO_0009963 | |
| Disease | age at onset, coronary stenosis | 8.44e-04 | 9 | 145 | 2 | EFO_0004847, MONDO_0006715 | |
| Disease | cortical surface area measurement | PALD1 KIF6 MYH10 CNNM2 FAT3 KHNYN SREBF1 CUL9 DNAH7 ARG1 KIAA0825 SND1 PRKAR2A TLN2 PRKD1 TANGO6 | 9.75e-04 | 1345 | 145 | 16 | EFO_0010736 |
| Disease | unipolar depression, bipolar disorder | 1.06e-03 | 156 | 145 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | osteoarthritis, hip | 1.12e-03 | 92 | 145 | 4 | EFO_1000786 | |
| Disease | Ischemic stroke | 1.14e-03 | 324 | 145 | 7 | HP_0002140 | |
| Disease | rheumatoid arthritis (implicated_via_orthology) | 1.53e-03 | 12 | 145 | 2 | DOID:7148 (implicated_via_orthology) | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 1.60e-03 | 171 | 145 | 5 | DOID:9352 (is_implicated_in) | |
| Disease | schizophrenia, anorexia nervosa | 1.71e-03 | 48 | 145 | 3 | MONDO_0005090, MONDO_0005351 | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 1.81e-03 | 13 | 145 | 2 | DOID:0112202 (implicated_via_orthology) | |
| Disease | diastolic blood pressure, systolic blood pressure | 1.81e-03 | 670 | 145 | 10 | EFO_0006335, EFO_0006336 | |
| Disease | Streptozotocin Diabetes | 2.02e-03 | 108 | 145 | 4 | C0038433 | |
| Disease | Diabetes Mellitus, Experimental | 2.02e-03 | 108 | 145 | 4 | C0011853 | |
| Disease | Alloxan Diabetes | 2.02e-03 | 108 | 145 | 4 | C0002152 | |
| Disease | Hamman-Rich syndrome | 2.10e-03 | 14 | 145 | 2 | C0085786 | |
| Disease | pimelic acid measurement, 3-methyladipic acid measurement | 2.10e-03 | 14 | 145 | 2 | EFO_0010449, EFO_0010524 | |
| Disease | bone fracture | 2.30e-03 | 112 | 145 | 4 | EFO_0003931 | |
| Disease | interleukin-6 measurement | 2.30e-03 | 112 | 145 | 4 | EFO_0004810 | |
| Disease | Colorectal Neoplasms | 2.54e-03 | 277 | 145 | 6 | C0009404 | |
| Disease | fourth ventricle volume measurement | 2.75e-03 | 16 | 145 | 2 | EFO_0010303 | |
| Disease | Pontoneocerebellar hypoplasia | 2.75e-03 | 16 | 145 | 2 | cv:C1261175 | |
| Disease | migraine without aura, susceptibility to, 4 | 2.75e-03 | 16 | 145 | 2 | MONDO_0011847 | |
| Disease | Astrocytosis | 3.11e-03 | 17 | 145 | 2 | C3887640 | |
| Disease | Gliosis | 3.11e-03 | 17 | 145 | 2 | C0017639 | |
| Disease | alcohol consumption measurement | MYH10 ANXA1 PCLO ANKS1B SRR INPP4B AKAP9 SND1 PRKAR2A RPRD2 CLEC16A ECE2 SENP7 TANGO6 | 3.30e-03 | 1242 | 145 | 14 | EFO_0007878 |
| Disease | rheumatoid arthritis, ACPA-positive rheumatoid arthritis, rheumatoid factor seropositivity measurement | 3.72e-03 | 63 | 145 | 3 | EFO_0000685, EFO_0007791, EFO_0009459 | |
| Disease | Congenital hernia of foramen of Morgagni | 3.88e-03 | 19 | 145 | 2 | C0265699 | |
| Disease | Congenital hernia of foramen of Bochdalek | 3.88e-03 | 19 | 145 | 2 | C0265700 | |
| Disease | sclerosing cholangitis | 4.24e-03 | 66 | 145 | 3 | EFO_0004268 | |
| Disease | schizophrenia (implicated_via_orthology) | 4.61e-03 | 68 | 145 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | Congenital diaphragmatic hernia | 4.74e-03 | 21 | 145 | 2 | C0235833 | |
| Disease | Idiopathic Pulmonary Fibrosis | 4.74e-03 | 21 | 145 | 2 | C1800706 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DIARISKDMEDSVGL | 91 | Q8TAA9 | |
| ELESTKAVIMGETAV | 196 | Q8WWZ7 | |
| KAVIMGETAVVEIDT | 201 | Q8WWZ7 | |
| ILKMIEEAGAIISTR | 76 | O00154 | |
| ETETLGALREMQDKV | 471 | Q96CN4 | |
| EEVLEKILVSGEMAA | 831 | A6H8Y1 | |
| VDEMETDLKTTGREG | 1166 | A6H8Y1 | |
| ETLEMGEVVEKDTTE | 926 | Q99996 | |
| ELMIGRKDVISVDAA | 471 | Q96N23 | |
| IDGVLDMRVSKVDTG | 631 | Q9P2I0 | |
| DMRVSKVDTGVILEE | 636 | Q9P2I0 | |
| RMEEQVTKAEAELGT | 151 | Q9NUP1 | |
| TEETEIMIVQAKGRG | 166 | O60885 | |
| GLMVVEEIISSEEEK | 136 | Q96BT7 | |
| GVDMIEAISLVREVT | 451 | O43306 | |
| VMVEEGFSTRDLLKE | 11 | Q96A70 | |
| SEMQDLEEIRKITGV | 546 | Q8N139 | |
| GIKVKDDMTEVTGRV | 396 | Q9UL18 | |
| TMEEVFLRVGKLVDS | 831 | Q99758 | |
| VRTVRAFGKEMTEIE | 361 | Q9NRK6 | |
| EKVEMLLGAETQSER | 756 | Q96DR7 | |
| METKRVEIPGSVLDD | 1 | Q8IU60 | |
| RSIEEVEADMKTLGV | 346 | O60826 | |
| TQEMEGIVIVKVEEE | 16 | Q8TCP9 | |
| RILTVLEEAMGTKTE | 431 | Q8TBG4 | |
| GIIKTVNEDVEEMEI | 1026 | Q9NRL2 | |
| GLPVVTREDVEEAMK | 86 | Q8IWF9 | |
| TEVDRLGIGKVMEET | 201 | P05089 | |
| VDFQMKTLIVDGERT | 576 | Q8IZ41 | |
| DIIAVMITELRGKDI | 151 | Q86XS8 | |
| LVRDVTEKMDVLGTV | 101 | Q9ULE6 | |
| VAVGELTDEDVKMIT | 451 | P49736 | |
| MVKGVDEATIIDILT | 56 | P04083 | |
| EEIDKIMSSIDVGIN | 781 | Q7Z6G8 | |
| ETEETEMKALGERVS | 896 | Q15139 | |
| RNVDLMDIKVGSVEE | 1081 | Q9BXT6 | |
| TSGILEKSDREVVME | 376 | Q8IV33 | |
| SGTVSEEIEVLEMVK | 186 | Q8N9B5 | |
| VGTIEVSVVKMGEIE | 176 | O15327 | |
| TTDDLSMLGRVVKVE | 596 | Q9NR82 | |
| QEMAEVRKDDVVTVT | 341 | Q8N0U4 | |
| MAGVVVRADILEDKD | 226 | P52272 | |
| AEVGKDERVITEEMN | 696 | O43491 | |
| DERVITEEMNGKEIS | 701 | O43491 | |
| SKEIAEGMISEIRTA | 501 | P0DPD6 | |
| IILDGIKMDTGVEVS | 366 | Q06265 | |
| GTMVTSTEEERKLLD | 2046 | Q9Y6V0 | |
| IRMLDGDVTDVVEAK | 276 | P29122 | |
| ALVILAKGAEEMETV | 6 | Q99497 | |
| IVMFEGATEEEKLLS | 471 | Q6NT32 | |
| NMILGDVEETVTTIE | 51 | P62310 | |
| LKDELAMVTGEQRTE | 371 | Q6ZMV9 | |
| TRLMEVSVTESGEIK | 226 | Q7LBC6 | |
| KRFDEILEVSDGIMV | 321 | P30613 | |
| RRSATKVMVVVTDGE | 271 | P17301 | |
| MALSTGDVVEVVEKS | 176 | A6NI72 | |
| MALSTGDVVEVVEKS | 151 | A8MVU1 | |
| VRIVGVEAESMDLVL | 91 | Q8NFY9 | |
| VTVFGDIVITKLMED | 2156 | Q9UMZ3 | |
| QEKEVRAMVGSDVEL | 21 | O75144 | |
| VESENERAGTVMEEK | 2236 | Q8NFC6 | |
| TGVNTEIGKIRDEMV | 226 | P16615 | |
| EIGKIRDEMVATEQE | 231 | P16615 | |
| AEGTVDKDTTIMELR | 891 | P46100 | |
| IVTVEERLATVKSGM | 506 | Q8N9C0 | |
| ETVEMDIRIGIVEHT | 386 | Q9NWB7 | |
| SIVTSGMREEKLLTE | 201 | Q12934 | |
| ILTDGVVTDMADTRE | 516 | Q9UBL6 | |
| SEIMIDAEGRIIDVI | 346 | Q6V1X1 | |
| VMIKTIETRDGEVVS | 446 | P17661 | |
| HMKSSEGEVVELIEI | 1116 | Q8WXX0 | |
| VMESDRVTEIVGVVS | 1371 | Q8TDW7 | |
| VREEMEKVLAGETLS | 176 | Q12906 | |
| LTEREKMDTGVVLLS | 186 | Q3MJ40 | |
| VEVDMRSIGIRVTEE | 316 | Q5T7N3 | |
| EVSERMKIVDVIGEK | 266 | P13861 | |
| RFMVKLAEETDGIIV | 526 | O15037 | |
| EKALGEISVSVEMAE | 531 | Q8IWT3 | |
| TGSTEDTILEKIREM | 341 | Q8IYT3 | |
| LTEREKMDTGVVLLS | 186 | A2RUR9 | |
| RELLDESQKVMVTVG | 1076 | Q9BYK8 | |
| RVEIIMKETVDAEGR | 236 | O95479 | |
| ETVGGDEIVMVIKDS | 141 | P31944 | |
| MELSDVEDDGSKIIV | 371 | Q5VT52 | |
| EAASIKEERGDEVMV | 46 | P35580 | |
| VVGKRKMIIEDETEF | 176 | Q8N1G2 | |
| TEELMIVLEQGTEVR | 76 | E9PI22 | |
| RFMVKLAEETDGIIV | 881 | Q9P2P1 | |
| VKRESVGMEVAVLTD | 716 | Q9P2E2 | |
| KRSTITDAGLEVMLE | 201 | Q8N461 | |
| KDIMTEISIISGELE | 636 | Q9BQF6 | |
| LGAEERIMQTVEITK | 176 | O43236 | |
| VEKIRGLMEDTTQLE | 491 | O75509 | |
| KGTSALMTVELDEER | 1826 | O95425 | |
| EGQGTLVKVEMVISE | 761 | Q14C87 | |
| GKRDSEMAVIVQDTE | 921 | Q13393 | |
| RMTGEEGKEVITEIE | 36 | Q5UIP0 | |
| EVVGKMVSSIIDSLE | 131 | Q5UIP0 | |
| KVLEGMEVVRKVEST | 171 | P23284 | |
| QVEVKMEGDSVLLEV | 131 | P04278 | |
| QREVEVEVESMDKAG | 591 | Q7KZF4 | |
| KLDDFVETGDIRTMV | 391 | Q14108 | |
| LDKMLVDDIGDVTIT | 41 | P17987 | |
| LIGEDKEAGTETVMR | 191 | Q9P0P8 | |
| TVGAVIVEEMRAAIE | 191 | Q9Y253 | |
| ENVAKRVTEETEGIM | 136 | Q9GZT4 | |
| MTDLLEEGITVVENI | 51 | O00186 | |
| VKVSAEEAGKTMVRE | 291 | O60287 | |
| EETELGVMEDQRSII | 386 | Q9BXB5 | |
| TEELMIVLEQGTEVR | 76 | P0DMB1 | |
| ALKMERVEESGVSIS | 911 | Q8TER0 | |
| VEESKDAGIRTLVML | 36 | P60880 | |
| DVLMEGVKTEVEDTL | 411 | P36956 | |
| SITEETILGAMKDVV | 641 | O75027 | |
| EEITAIVKMRVAGTA | 1151 | Q96P48 | |
| GIKTSGESEEIEMVI | 426 | Q2KHT3 | |
| QGALELRTKTVEDVM | 436 | Q9H8M5 | |
| MIQGALELRTKTVED | 361 | Q6P4Q7 | |
| LRVGDIVMVKEDETF | 146 | P98196 | |
| AVSMKVFREEDGVLI | 606 | Q9BXT8 | |
| ITEIKVVRGISMEEN | 611 | A4UGR9 | |
| AVMKRVVEDTTAIDV | 611 | Q9UID3 | |
| SEIGELKQEMVRTDV | 26 | Q8WYP3 | |
| EIGNLEKTRSIMAEE | 1006 | P82094 | |
| TTLGEKMTEEEVETV | 171 | P14649 | |
| VLEDGTEVRSKMVLS | 326 | Q8N2H3 | |
| LDDVEGMSVRQLKEI | 261 | Q969K3 | |
| SLKARAVLIDMEEGV | 66 | Q9UJT0 | |
| EVGEAMRELSEVKDS | 116 | Q99962 | |
| GRVRIEKMSSEVVDS | 36 | Q9GZZ9 | |
| ILRQLEVAGKEMSEE | 166 | Q8N4C7 | |
| EVDRMVLVGDVKDRV | 201 | P11908 | |
| KMSDILAEGITIVED | 46 | Q15833 | |
| ERSTEGVDIVMDNLK | 1671 | Q6ZS81 | |
| GIMITIKEAISDEDE | 546 | Q9C0B7 | |
| SVKIMEEKRDESTGV | 36 | Q8N945 | |
| FGMTETERKEVDEQI | 636 | Q2NKQ1 | |
| EGGEIIVTDMDTIEK | 496 | P22314 | |
| KSEERSGVIREVMII | 141 | Q8N3Z6 | |
| TVMVDDSKTVGELLV | 101 | Q9Y4G6 | |
| EVDRMVLVGDVKDRV | 201 | P60891 | |
| RMEKVVSEIESGFLL | 1591 | Q01118 | |
| LTVIKMEEAGDEIVS | 391 | Q7Z2W7 | |
| FVMEESTERKVIKGE | 96 | Q16600 | |
| VLERIMGDKVASEAL | 286 | Q15063 | |
| EDKVMTEERGILSGT | 91 | Q8N988 | |
| MQRDKTVVEERVGEE | 76 | A0A590UK83 | |
| LVSMDTEDVVRFEVG | 81 | P21754 | |
| EEGRMESVKTVTTEE | 221 | Q8N228 | |
| MIRDAKTEEGLTEEN | 721 | Q9UBN4 | |
| AGTKFEIVRLVIDEM | 46 | Q6ZT98 | |
| KIGLRVSIDTDMVEF | 1476 | Q7Z3T8 | |
| VSESIGVMEVKVLRT | 541 | P57103 | |
| ETGVEVKDIELVMSQ | 2036 | E9PAV3 | |
| VDETGVEVKDIELVM | 171 | Q13765 | |
| EVMVETVVTKEGLSE | 1081 | Q5VU43 |